Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, April 2007, p. 1164-1171, Vol. 51, No. 4
0066-4804/07/$08.00+0 doi:10.1128/AAC.00772-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.


biewski,1,
J.
yliñska,1
P. Mieczkowski,1,
M. Gniadkowski,2
J. Bardowski,1 and
P. Ceg
owski1
Department of Microbial Biochemistry, Institute of Biochemistry, and Biophysics of Polish Academy of Sciences,1 National Institute of Public Health, Warsaw, Poland2
Received 26 June 2006/ Returned for modification 13 August 2006/ Accepted 3 December 2006
|
|
|---|
|
|
|---|
The plasmidic blaSHV-5 gene was identified in 12 Escherichia coli isolates recovered during a clonal outbreak in a Warsaw, Poland, hospital in 1997 (25). All of the isolates exhibited identical levels of resistance to non-ß-lactam antibiotics (aminoglycosides); but many of the isolates differed in their levels of resistance to expanded-spectrum cephalosporins and could be separated into two groups, "resistant" and "susceptible," for which the MICs of ceftazidime were >128 µg/ml and 4 µg/ml, respectively. PstI restriction analysis of plasmids isolated from the "resistant" and "susceptible" groups revealed identical restriction patterns except for some fragments present in nonequimolar amounts in the "resistant" plasmid (25). Two of these fragments were subsequently found by hybridization with the gene-specific probe to contain the blaSHV gene. These facts indicated that the "resistant" phenotype correlated with the multiplication of a plasmid region comprising blaSHV. A study was commenced in order to understand the phenomenon of the plasmid fragment amplification. The first step of the project was to reveal the complete sequence of one of plasmids of the "susceptible" group, p1658/97, which is a presumed initial molecule in the amplification process. The results of the nucleotide sequence analysis and identification of the region within the blaSHV-5 gene that undergoes amplification are presented in this paper.
|
|
|---|
and A15 (3, 25).
Conjugation assay.
One-milliliter volumes of cultures of the donor and recipient strains (109 CFU of each strain per ml) grown in Luria-Bertani (LB) medium (Biocorp, Warsaw, Poland) were mixed and incubated for 30 min at 37°C. E. coli A15 or DH5
, both of which are resistant to rifampin, was used as the recipient strain. Transconjugants were selected on LB agar (Biocorp) supplemented with ceftazidime (10 µg/ml; GlaxoSmithKline, Stevenage, United Kingdom) and rifampin (100 µg/ml; Polfa Tarchomin, Warsaw, Poland).
Selection of E. coli "resistant" clones carrying p1658/97 with the amplified blaSHV-5 gene.
One-hundred microliters of the E. coli DH5
(p1658/97) overnight culture or its appropriate dilution was plated on LB agar, and then a sterile disk (diameter, 10 mm; Whatman 3MM paper) with 50 µg of ceftazidime was placed on it. The plates were incubated overnight at 37°C. The E. coli clones able to form colonies inside the zone of growth inhibition were collected as "resistant" colonies.
DNA cloning and sequencing. The vectors were purified by using a Plasmid Midi AX DNA purification kit (A&A Biotechnology, Gdañsk, Poland). A large amount of p1658/97 DNA for random library construction, direct sequencing, and digestions was prepared by the alkaline lysis procedure (2), followed by CsCl-ethidium bromide gradient ultracentrifugation (36). The library of random fragments of p1658/97 was prepared by sonication by the procedure used for sequencing of the Haemophilus influenzae Rd genome (42). Fragments of between 1.6 and 2.0 kb were cloned into a unique SmaI site of the pSGMU2 vector (8). The plasmid DNA from the resulting subclones was purified prior to sequencing by using DNA purification kits (Macherey & Nagel, Düren, Germany; QIAGEN, Hilden, Germany). Cycle sequencing was performed with the use of BigDye (version 1.0 or 2.0; Applied Biosystems, Foster City, CA) in a GeneAmp 9700 PCR system (Applied Biosystems). Samples were subsequently purified on CentriSep columns (Applied Biosystems) or subjected to sodium acetate-ethanol precipitation, according to the protocol of the BigDye kit manufacturer. Extension products were separated on an ABI 377 automated sequencer (Applied Biosystems). Sequencing was performed with random library clones, the PCR products, and p1658/97 as templates. In the last case, a BAC sequencing protocol was used (Applied Biosystems). All enzymes used for DNA manipulations were from MBI Fermentas, Vilnius, Lithuania.
PCR amplification of the cat cassette. Primers chlL (5'-ATCCGCTTATTATCACTTATTCAGG-3') and chlP (5'-GGTGTCCCTGTTGATACCGG-3') were used for amplification of the cat gene of pACYC184 (5). The reaction conditions were as follows: 3 min at 95°C; 25 cycles of 30 s at 94°C, 30 s at 48°C, and 30 s at 72°C; and finally, 7 min at 72°C. The resulting PCR products were run in 1% agarose gels (SeaKem; FMC Bioproducts, Rockland, ME) and purified for cloning by using a DNA Gel-Out gel extraction kit (A&A Biotechnology).
Plasmid sequence analysis. The resulting nucleotide sequences were assembled by using the DNA Lasergene 99 package (DNASTAR, Madison, WI); and analysis and annotation of the sequence were performed by additionally using Glimmer 2.0 (The Institute for Genomic Research, 1999 [35]; RBSFinder.pl [The Institute for Genomic Research]; SignalP [CBS; www.cbs.dtu.dk/services/SignalP-2.0/] [24]), InteroScan (Expasy; www.ebi.ac.uk/InteroScan/ [45]), and TMHMM Server (version 2.0; CBS; www.cbs.dtu.dk/services/) software.
Nucleotide sequence accession number. The complete nucleotide sequence of plasmid p1658/97 has been submitted to the GenBank database under accession no. AF550679.
|
|
|---|
. The transconjugants of A15 (RecA+), as well as those of DH5
(RecA), were obtained; and subsequently, 10 of them were subjected to the ceftazidime disk test. All clones tested were able to form colonies inside the growth inhibition zone. Restriction analysis of the p1658/97 plasmids recovered from these colonies with the rare cutting enzyme, SwaI, revealed that one band was nonproportionally more intense when compared with p1658/97 isolated from the "susceptible" colony taken from outside the inhibition zone (Fig. 1). Although similar data were previously shown for plasmids p1657/97 and p1658/97 (extracted from "resistant" and "susceptible" clinical isolates, respectively) (25), this result indicated that acquisition of the "resistance" phenotype can proceed in a RecA-independent manner. Moreover, as shown in Fig. 1, comparison of the SwaI digestion of p1657/97 isolated from the E. coli DH5
strain cultured in the presence of 128 µg/ml ceftazidime with that of p1658/97 isolated from the "resistant" DH5
colony revealed similar restriction patterns, with the overrepresented DNA fragments isolated from the plasmids being of identical sizes and similar intensities. This indicated that in both p1658/97 from the "resistant" DH5
colony and p1657/97 the same region underwent amplification, pointing to the identical mechanism of this event. Therefore, the p1658/97 plasmid isolated from the "susceptible" DH5
clone was subjected to DNA sequence analysis.
![]() View larger version (92K): [in a new window] |
FIG. 1. SwaI digestion of p1658/97 and p1657/97. The results of SwaI digestion of p1658/97 DNA with the "nonamplified" and the "amplified" regions isolated from E. coli colonies collected from outside and inside the growth inhibition zone ("susceptible" and "resistant," respectively) and p1657/97 isolated from DH5 cultured with the presence of 128 µg/ml ceftazidime are shown. Equal amounts of all plasmids were loaded. The lanes are described at the top. The arrow shows the amplified fragment of 8,817 bp. Lane M, GeneRuler DNA Ladder Mix (MBI Fermentas). Numbers on the left are in base pairs.
|
Two main parts can be distinguished in the p1658/97 sequence, based on the over 90% similarity to other DNA molecules at the nucleotide level. The first part, which covers about 61 kb, i.e., 48% of p1658/97 (Fig. 2), demonstrates homology with sequences of conjugative plasmids F (sex factor; 99 kb; GenBank accession no. AP001918) and R100 (resistance to mercuric ions, streptomycin, chloramphenicol, and tetracycline; 94 kb; GenBank accession no. AP000342). The F/R100-like sequence comprises one large cluster and two smaller clusters of genes. The large cluster (positions 114495 to 43552) is interrupted by orf62 and contains genes responsible for conjugative transfer, postsegregational killing (two systems), and plasmid replication (system IncFII). Of the two smaller regions, the first one spans 2 kb (positions 99420 to 101435) and encompasses another plasmid replication system (IncFIB), whereas the second one, which is 3.5 kb (positions 109127 to 112552), encodes the active partition system, as well as orf53, which is of unknown function. The latter segment is flanked by two IS1 copies, suggesting that it was acquired by p1658/97 via an IS1-mediated recombination event.
![]() View larger version (75K): [in a new window] |
FIG. 2. Graphical overview of p1658/97. ORFs are shown by arrows: p1658/97-specific ORFs are in black, ORFs homologous to genes of known function are in white, and ORFs homologous to genes of unknown function are in gray. The positions of mobile elements are additionally shown as white boxes. The orientations of the mobile elements are marked with black arrows; incomplete mobile elements are marked by a symbol. Regions of over 90% similarity (at the nucleotide level) to the following DNA molecules are shown by shadings according to the legend: 1, plasmid F; 2, plasmid R100; 3, both plasmids F and R100; 4, the chromosomes of both E. coli and S. enterica serovar Typhimurium; 5, a region found in the K. pneumoniae chromosome and plasmids pHNM1, pSEM, and pACM1; 6, P. rettgeri genomic island R391 and the Vibrio cholerae STX transposon; 7, plasmid R64; 8, p1658/97-specific regions; 9, a region shared with pSEM, pACM1, and some other plasmids containing an integron; and 10, DNA molecules other than those mentioned above. The functional modules of p1658/97 outside the circle are indicated as follows: PAR, partition; PSK, postsegregational killing; REP, replication. The G+C contents of the sequence blocks are denoted in the inner circle.
|
The mean G+C content of the p1658/97 nucleotide sequence is 50.5%, which is consistent with the average amount of G+C found in the genomes of members of the family Enterobacteriaceae. However, the G+C content among the particular sequence blocks of p1658/97 varies from 30% to 69%. Four blocks with mean G+C contents different from the average by more than 10% are marked in Fig. 2, and their borders are superimposed with some of the mosaic subregions homologous to DNA molecules other than F and R100.
Plasmid backbone. The functional modules of the plasmid backbone coding for replication, conjugative transfer, and the stable maintenance of p1658/97 have homologs in either F or R100, or both, suggesting that all three of these plasmids evolved from a common ancestor.
The functionalities of two replication systems found in p1658/97, IncFIB (positions 99420 to 101435) and IncFII (positions 37402 to 39441), were tested in E. coli. The replicons were separated by construction of two p1658/97 derivatives, pR and pFBAMP, which contain the IncFII and IncFIB replication systems, respectively. These plasmids were introduced into E. coli DH5
cells. In both cases transformants were obtained, and the reisolation of the introduced plasmids (data not shown) demonstrated that the two replication systems of p1658/97 are functional in E. coli.
The stability of p1658/97 in a bacterial population might be ensured by two mechanisms: active partition determined by the sopABC operon (positions 109127 to 111994) and homologous to that of the plasmid F (11, 15) and two postsegregational killing systems, pemI/pemK (downstream of the IncFII replication module; positions 40555 to 41158) (40) and hok/sok (positions 124314 to 124583) (37). Both of these systems are identical to those in their R100 counterparts.
The conjugative transfer of plasmid p1658/97 is ensured by the products of the tra and trb genes. These genes are organized in a 33.3-kb operon (positions 2103 to 35307) that is almost identical at the nucleotide level to the tra operon found in the F plasmid (U01159) and that consists of 36 genes: 24 tra genes, 10 trb genes, artA, and finO (10). Nevertheless, two differences between these tra operons have been found. The first one is a frame shift in the trbF gene, creating the stop codon that results in shortening of the TrbF protein of p1658/97 by 25 amino acids. The TrbF function is unknown, but it is predicted to be an integral membrane protein (10). The second difference concerns the finO sequence, which codes for a conjugation regulatory function. In the F plasmid, this gene is interrupted by IS3a, resulting in an increase in transfer frequency in broth, evaluated as one transconjugant per donor cell (10, 38). In contrast to the sequence of the F plasmid, no IS(s) has been found within finO of p1658/97. The conjugative transfer frequency of p1658/97 in liquid medium was measured to be 4.5 x 103 ± 4.1 x 104 transconjugants per donor cell. This value seemed to be significantly lower than the transfer frequency of the F plasmid and could have been caused by the presence of the functional finO sequence (10, 38).
Mobile elements. Nineteen mobile elements identified in p1658/97 constituted about 14% of the plasmid sequence and are listed in Table 1. All of them (e.g., IS26, IS1, and IS100), except for the remnant of Tn21, are situated within the region of similarity to other than F or R100 molecules. The fragment of Tn21 is localized downstream of the IncFII replicon; thus, it has the same localization as that in the R100 plasmid, in which its complete version is found. The mobile elements of p1658/97 separate subregions of different homologies, which suggests their involvement in the mobilization of these subregions to the plasmid molecule.
|
View this table: [in a new window] |
TABLE 1. Mobile elements found in p1658/97a
|
IS26, respectively). The aadA1, aacC1, and aacA4 gene cassettes form the variable region, together with two ORFs, orfX and orfX', which code for polypeptides of unknown function. The identical composition of the gene cassette array has been found in integron INTCZD37 from K. pneumoniae (GenBank accession no. AF282595); integron In-t3, which is present in plasmid pSEM (20, 39); an integron from plasmid pACM1 (20, 29, 30, 31); and an integron from Acinetobacter baumannii (GenBank accession no. DQ370505). The sequence identities of the variable regions of these integrons vary between 99 and 100%. The p1658/97 integron contains the complete 3' conserved sequence (3'-CS) with the left inverted repeat (IRt), whereas its 5'-CS is truncated by 113 bp at the 5' end (89 bp from the stop codon of intI1) due to the IS26 insertion (IS26/
5'-CS). The insertion produced the incomplete copy of the element (
IS26) and caused the lack of the integron's right inverted repeat (IRi). An identical IS26/
5'-CS has been reported in integrons in three plasmids belonging to the IncL/M group, the aforementioned plasmids pSEM (20, 39), pACM1 (20, 29, 30, 31), and pAK33 from K. pneumoniae (In111; GenBank accession no. AY260546) (20, 44), and also in plasmid p541 from E. coli, which belongs to the IncN group (In-e541; GenBank accession no. AY340637) (20, 21, 43). The integrons of p1658/97, pSEM, and pACM1 are associated with the almost identical region encompassing the blaSHV-5 gene and are flanked by two IS26 copies (IS26cp3 and IS26cp4; see below); however, the mutual localization of the integron and this region is different in all three molecules (20, 29). In p1658/97 and pACM1, the integron is localized downstream of the blaSHV-5 gene-containing region, but in pSEM it is inverted and placed upstream. In both pACM1 and pSEM, the complete IS26 copy was found at the 5'-CS of the integrons, whereas in p1658/97 it is truncated (
IS26). Moreover, in pACM1 the integron and the blaSHV-5-containing region are separated by another unrelated integron that is adjacent to IS1, and the IS6100 element was identified in the 3'-CS of the pSEM integron.
![]() View larger version (24K): [in a new window] |
FIG. 3. Schematic representation of the multiresistance locus of p1658/97 with the amplicon and the integron. Black arrows indicate IS26, gray arrows represent genes localized within the integron and the amplicon, and white arrows indicate the remnant of IS26 ( IS26) and the blaSHV-5 gene. The position of SwaI and the sizes of the restriction fragments are indicated.
|
IS26" region, and the "IS26cp3-blaSHV-5-IS26cp4" region. This finding suggests that the 48-kb segment of p1658/97 could have originated from the IS26-mediated transposition of a composite element from an unidentified molecule into the site adjacent to the incomplete Tn1 copy (Fig. 4). On the other hand, the structure of this segment itself probably arose from a variety of separate integration events that implanted other mobile elements present within this region. The "IS26cp2-integron-
IS26" and "IS26cp3-blaSHV-5-IS26cp4" regions that are localized within the 48-kb segment of p1658/97 have the structure of a composite transposon type I themselves. However, the lack of DRs at their ends suggests, rather, recombination as a mechanism of their acquisition by p1658/97, similar to that for the IS26-flanked DNA fragments observed in plasmids pSEM, pAK33, p541, pACM1 (20), and pHNM1. It is impossible to elucidate whether the full structure of the 48-kb segment was formed before or after the recruitment of the putative composite transposon into p1658/97.
![]() View larger version (23K): [in a new window] |
FIG. 4. Hypothetical events leading to the present structure of p1658/97. The partial p1658/97 sequence (positions 35000 to 114500) is drawn to scale; the remaining part (including the tra region) is out of scale. The module "IS26cp1-spacing region-IS26cp4" (positions 47137 to 95371) is marked at the top. Open boxes represent the mobile elements, and arrows represent ORFs. The orientations of the mobile elements are marked with black arrows; incomplete mobile elements are marked with a symbol. Dotted lines show hypothetical mobilization events that implant different submodules. The regions of the plasmid backbone are marked: REP, replication; PAR, partition; PSK, postsegregational killing. DRs, when they have been identified, are shown. Regions of over 90% similarity (at the nucleotide level) to DNA molecules other than F and R100 are shown.
|
The details of gene amplification in plasmid p1658/97 are the subject of a further study. Preliminary results, which have shown no difference in the amplification frequencies of RecA-proficient and RecA-deficient E. coli isogenic strains bearing p1658/97 (tested on medium with 30 µg/ml ceftazidime), suggest, rather, the RecA independence of the process studied. However, when high antibiotic pressure was applied (128 µg/ml ceftazidime), approximately 100-fold more "resistant" colonies were obtained for the RecA-proficient strain. Simultaneously, "resistant" clones selected with 128 µg/ml ceftazidime harbored plasmids with significantly more copies of the amplified blaSHV-5 region than those isolated with 30 µg/ml ceftazidime, irrespective of the RecA content (data not shown). These results led to the speculation that the RecA protein could be involved in amplification only subsequent to the RecA-independent amplification, when several amplicon copies are available. Similar results have been demonstrated for plasmid NR1, in which the initial duplications of the amplifiable region flanked by IS1 occurred in the RecA-independent but IS1-mediated manner, and these duplications were a limiting step for further RecA-mediated multiplication (28).
Amplicon structure. The organization of the amplicon is shown in Fig. 3. Apart from blaSHV-5, the region contains an incomplete operon involved in sugar metabolism (truncated ygbM and genes fucA, ygbK, and ygbJ) and its regulatory gene (ygbI) in p1658/97, named ORFs 36 to 39 and 40, respectively (41, 46); a gene coding for a putative RecF protein with the incomplete catalytic domain (orf42) (9); and a truncated lacY gene, which encodes the lactose transport protein. As mentioned above, the DNA fragment located between the two IS26 elements was found to be a derivative of the K. pneumoniae chromosome (20, 39), which could be expected, considering the earlier data indicating that this species is a source of blaSHV genes (4, 6, 7, 13, 16). The presence of the same segment of K. pneumoniae DNA flanked by two IS26 elements in p1658/97, pSEM, pACM1, and pHNM1 indicates that it probably arose from a single escape from the K. pneumoniae chromosome and later became disseminated into a variety of plasmid molecules. Interestingly, as already mentioned, pHNM1, pSEM, and also pACM1 belong to the IncL/M incompatibility group and are able to replicate in a broad range of hosts (38). This fact emphasizes the possibility of the spread of the amplicon among various DNA replicons and bacterial species. Similar fragments of the K. pneumoniae chromosome with blaSHV genes have also been found within other partially sequenced plasmids: pZMP1 (GenBank accession no. X53817; K. pneumoniae), pPa-1 (GenBank accession no. AF074954; P. aeruginosa), pNSF-1 (GenBank accession no. AF282921; Shigella flexneri) (9), and pPAG-KE (GenBank accession no. AF096930; P. aeruginosa). The structures of plasmids pZMP1 and pPa-1 show the association of SHV-type ß-lactamase genes with IS26 as well. The results presented and discussed above strongly support the hypothesis that IS26 plays a major role in mobilization of the blaSHV genes from the K. pneumoniae genome and their further dissemination to a wide range of enterobacterial strains (6).
Conclusions. We report here the complete nucleotide sequence of a plasmid in which ESBL gene blaSHV-5 undergoes amplification. This process results in the high-level resistance of clinical isolates to ß-lactam antibiotics, including expanded-spectrum cephalosporins. The amplicon originated by mobilization from the chromosome of K. pneumoniae and was later spread into several different plasmids and, by means of their horizontal transfer, to a variety of bacterial species over a wide geographic area. Although the amplicon is flanked by two IS26 elements and thus has a structure of a type I composite transposon, the major way of its dissemination among DNA replicons is probably mediated by recombination by IS26 copies, which is a subject of our further studies. This work, together with several other investigations (7, 14, 17, 20, 23), strongly underlines the important role of IS26 in the spread of ß-lactamase genes acquired by clinical bacterial populations, especially those coding for the SHV-type enzymes.
owski until he passed away in 2004. We thank Alessandra Carattoli for kindly providing plasmid pSEM.
This work was supported by a grant in the Fifth EU Frame Project for PC (grant ICA-CT-2000-70010).
Published ahead of print on 12 January 2007. ![]()
Present address: Department of Biotechnology, Faculty of Biology and Earth Sciences, Nicolaus Copernicus University, Toruñ, Poland. ![]()
Present address: Department of Molecular Genetics and Microbiology, Box 3054, Duke University, Durham, NC 27710. ![]()
|
|
|---|
ucha, A., B. Mikiewicz, and M. Gniadkowski. 1999. Diversification of Escherichia coli expressing an SHV-type extended-spectrum-lactamase (ESBL) during a hospital outbreak: emergence of an ESBL-hyperproducing strain resistant to expanded-spectrum cephalosporins. Antimicrob. Agents Chemother. 43:393-396.This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»